These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36298688)

  • 1. Multifaceted Aspects of HIV-1 Nucleocapsid Inhibition by TAR-Targeting Peptidyl-Anthraquinones Bearing Terminal Aromatic Moieties.
    Sosic A; Frecentese F; Olivato G; Rollo D; Carraro C; Gamba E; Santagada V; Gatto B
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Natural Linker Configuration in 2,6-Dipeptidyl-Anthraquinones Enhances the Inhibition of TAR RNA Binding/Annealing Activities by HIV-1 NC and Tat Proteins.
    Sosic A; Saccone I; Carraro C; Kenderdine T; Gamba E; Caliendo G; Corvino A; Di Vaio P; Fiorino F; Magli E; Perissutti E; Santagada V; Severino B; Spada V; Fabris D; Frecentese F; Gatto B
    Bioconjug Chem; 2018 Jul; 29(7):2195-2207. PubMed ID: 29791798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of HIV-1 Nucleocapsid Protein Inhibition by Lysyl-Peptidyl-Anthraquinone Conjugates.
    Sosic A; Sinigaglia L; Cappellini M; Carli I; Parolin C; Zagotto G; Sabatino G; Rovero P; Fabris D; Gatto B
    Bioconjug Chem; 2016 Jan; 27(1):247-56. PubMed ID: 26666402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid conformational changes essential for HIV-1 nucleocapsid protein-mediated inhibition of self-priming in minus-strand transfer.
    Hong MK; Harbron EJ; O'Connor DB; Guo J; Barbara PF; Levin JG; Musier-Forsyth K
    J Mol Biol; 2003 Jan; 325(1):1-10. PubMed ID: 12473448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein.
    Sosic A; Olivato G; Carraro C; Göttlich R; Fabris D; Gatto B
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33810333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic studies of mini-TAR RNA/DNA annealing in the absence and presence of HIV-1 nucleocapsid protein.
    Vo MN; Barany G; Rouzina I; Musier-Forsyth K
    J Mol Biol; 2006 Oct; 363(1):244-61. PubMed ID: 16962137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted binding of nucleocapsid protein transforms the folding landscape of HIV-1 TAR RNA.
    McCauley MJ; Rouzina I; Manthei KA; Gorelick RJ; Musier-Forsyth K; Williams MC
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13555-60. PubMed ID: 26483503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in Vitro Screening of New Series of 2,6-Dipeptidyl-anthraquinones: Influence of Side Chain Length on HIV-1 Nucleocapsid Inhibitors.
    Frecentese F; Sosic A; Saccone I; Gamba E; Link K; Miola A; Cappellini M; Cattelan MG; Severino B; Fiorino F; Magli E; Corvino A; Perissutti E; Fabris D; Gatto B; Caliendo G; Santagada V
    J Med Chem; 2016 Mar; 59(5):1914-24. PubMed ID: 26797100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence.
    Bernacchi S; Stoylov S; Piémont E; Ficheux D; Roques BP; Darlix JL; Mély Y
    J Mol Biol; 2002 Mar; 317(3):385-99. PubMed ID: 11922672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of nucleic acid structure and stability modulates the efficiency of minus-strand transfer mediated by the HIV-1 nucleocapsid protein.
    Heilman-Miller SL; Wu T; Levin JG
    J Biol Chem; 2004 Oct; 279(42):44154-65. PubMed ID: 15271979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single aromatic residue location alters nucleic acid binding and chaperone function of FIV nucleocapsid protein.
    Wu H; Wang W; Naiyer N; Fichtenbaum E; Qualley DF; McCauley MJ; Gorelick RJ; Rouzina I; Musier-Forsyth K; Williams MC
    Virus Res; 2014 Nov; 193():39-51. PubMed ID: 24915282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities and differences in the nucleic acid chaperone activity of HIV-2 and HIV-1 nucleocapsid proteins in vitro.
    Pachulska-Wieczorek K; Stefaniak AK; Purzycka KJ
    Retrovirology; 2014 Jul; 11():54. PubMed ID: 24992971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Destabilization of the HIV-1 complementary sequence of TAR by the nucleocapsid protein through activation of conformational fluctuations.
    Azoulay J; Clamme JP; Darlix JL; Roques BP; Mély Y
    J Mol Biol; 2003 Feb; 326(3):691-700. PubMed ID: 12581633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleocapsid Annealing-Mediated Electrophoresis (NAME) assay allows the rapid identification of HIV-1 nucleocapsid inhibitors.
    Sosic A; Cappellini M; Scalabrin M; Gatto B
    J Vis Exp; 2015 Jan; (95):52474. PubMed ID: 25650789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific interactions between HIV-1 nucleocapsid protein and the TAR element.
    Kanevsky I; Chaminade F; Ficheux D; Moumen A; Gorelick R; Negroni M; Darlix JL; Fossé P
    J Mol Biol; 2005 May; 348(5):1059-77. PubMed ID: 15854644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the terminal bulges of HIV-1 cTAR DNA on its stability and the destabilizing activity of the nucleocapsid protein NCp7.
    Beltz H; Azoulay J; Bernacchi S; Clamme JP; Ficheux D; Roques B; Darlix JL; Mély Y
    J Mol Biol; 2003 Apr; 328(1):95-108. PubMed ID: 12684000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal zinc finger and flanking basic domains represent the minimal region of the human immunodeficiency virus type-1 nucleocapsid protein for targeting chaperone function.
    Mitra M; Wang W; Vo MN; Rouzina I; Barany G; Musier-Forsyth K
    Biochemistry; 2013 Nov; 52(46):8226-36. PubMed ID: 24144434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA.
    Guo J; Henderson LE; Bess J; Kane B; Levin JG
    J Virol; 1997 Jul; 71(7):5178-88. PubMed ID: 9188585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. During the early phase of HIV-1 DNA synthesis, nucleocapsid protein directs hybridization of the TAR complementary sequences via the ends of their double-stranded stem.
    Godet J; de Rocquigny H; Raja C; Glasser N; Ficheux D; Darlix JL; Mély Y
    J Mol Biol; 2006 Mar; 356(5):1180-92. PubMed ID: 16406407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 Tat-TAR interaction by diphenylfuran derivatives: effects of the terminal basic side chains.
    Gelus N; Bailly C; Hamy F; Klimkait T; Wilson WD; Boykin DW
    Bioorg Med Chem; 1999 Jun; 7(6):1089-96. PubMed ID: 10428378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.